Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
VentriPoint Diagnostics Ltd
V.VPT
Alternate Symbol(s):
VPTDF
Healthcare
Medical Devices
Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in...
oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:VPT)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(91)
•••
jopatclo
X
View Profile
View Bullboard History
Comment by
jopatclo
on Jun 24, 2024 8:56am
RE:New job by University Hospitals of Leicester NHS Trust
Very impressive and exciting to see Ventripoint specified in their post (New job posting by University Hospitals of Leicester NHS Trust) "Our department has a range of high specification
...more
(91)
•••
jopatclo
X
View Profile
View Bullboard History
Post by
jopatclo
on Jun 24, 2024 6:52am
Hugh presenting To some of Canada's top healthcare leaders
Good comment on post Miro TOMORROWS This is what Ventripoint's CEO Hugh MacNaught will be presenting on June 25th at The Data Effect in Vancouver, to some of Canada's top health care
...more
(91)
•••
jopatclo
X
View Profile
View Bullboard History
Post by
jopatclo
on Jun 24, 2024 6:03am
New job by University Hospitals of Leicester NHS Trust
Good DD "Our department has a range of high specification echocardiography machines and analytical software, including Ventripoint. All of which have strain and 3D capability."
...more
(91)
•••
jopatclo
X
View Profile
View Bullboard History
Post by
jopatclo
on Jun 22, 2024 9:18am
Bring new diagnostic and treatment technologies tothe market
Bart HendriksBart Hendriks • Following • FollowingEntrepreneurial CEO and Strategic Advisor in the field of MedTech, with expertise in pioneering clinical AI applications and cutting-edge technology
...more
(91)
•••
jopatclo
X
View Profile
View Bullboard History
Comment by
jopatclo
on Jun 22, 2024 9:17am
RE:Bart Hendriks post
Bart Hendrix does a lot of work, posting on several groups. Dr. Adams has a great team with Ventripoint. -Venture Capital Fund, Startup, and Angel Investors ***Over 77,000 Members*** Meetings Every
...more
(91)
•••
jopatclo
X
View Profile
View Bullboard History
Post by
jopatclo
on Jun 22, 2024 8:18am
Bart Hendriks post
Private Equity & Venture Capital Investors *438,000+ Members* | In-Person Investor NetworkingPrivate Equity & Venture Capital Investors *438,000+ Members* | In-Person Investor NetworkingBart
...more
(91)
•••
jopatclo
X
View Profile
View Bullboard History
Post by
jopatclo
on Jun 22, 2024 8:10am
This is what VPT CEO Hugh will be presenting on June 25th🚀
Interesting comment This is what Ventripoint's CEO Hugh MacNaught will be presenting on June 25th at The Data Effect in Vancouver, Miro CernetigMiro Cernetig
...more
(91)
•••
jopatclo
X
View Profile
View Bullboard History
Post by
jopatclo
on Jun 22, 2024 7:34am
👀Hugh and Hannah likes post Fantastic team work 👏
Interesting Hannah Crane and Hugh MacNaught likes post Fantastic team work Hannah CraneView Hannah
...more
(91)
•••
jopatclo
X
View Profile
View Bullboard History
Comment by
jopatclo
on Jun 21, 2024 3:26pm
RE:RE:RE: Very good article 🚀Conclusion 👏
Miro CernetigMiro Cernetig • 3rd+ • 3rd+CEO and Owner of CityAge.com Join CityAge’s global network of over 25,000 visionaries to connect with technologies and people building the future. Free
...more
(1567)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Jun 21, 2024 1:58pm
RE:RE:RE: Very good article 🚀Conclusion 👏
Looks like 556,000 shares on all Exchanges at this time. Hitting a high of 23.5 cents but settled back at 21 cents at the moment (2 p.m. EDT)
(91)
•••
jopatclo
X
View Profile
View Bullboard History
Comment by
jopatclo
on Jun 21, 2024 1:10pm
RE:RE:RE: Very good article 🚀Conclusion 👏
good comment and very nice Chart..Very bullish signal, crossing of 3 moving averages, 2 28 minutes ago @cardinal Too
...more
(826)
•••
chry200030
X
View Profile
View Bullboard History
Comment by
chry200030
on Jun 21, 2024 12:52pm
RE:RE: Very good article 🚀Conclusion 👏
Just a matter of time we make a new 52-week high.. That's about 60% gain. Then we'll be at .37. Game on.
(91)
•••
jopatclo
X
View Profile
View Bullboard History
Comment by
jopatclo
on Jun 21, 2024 12:29pm
RE: Very good article 🚀Conclusion 👏
now 0.2069$ on VPTD-F 11:32 D 0,2069 0,0499 News at any time..Like Bart's post this morning V4.0 FDA,Ascend cardiovascular,close
...more
(91)
•••
jopatclo
X
View Profile
View Bullboard History
Post by
jopatclo
on Jun 21, 2024 7:39am
Very good article 🚀Conclusion 👏
Very good article Conclusion While AI's full integration into daily clinical practice may still be on the horizon, its application in clinical trials, particularly in cardiology, is not
...more
(91)
•••
jopatclo
X
View Profile
View Bullboard History
Post by
jopatclo
on Jun 21, 2024 7:33am
VMS+ tech. and its unique contributions to advancing cardiac
Bart HendriksBart Hendriks• Following• FollowingEntrepreneurial CEO and Strategic Advisor in the field of MedTech, with expertise in pioneering clinical AI applications and cutting-edge technology
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Undervalued Oil & Gas Play Readies for Strong H2 2024 with Canadian and US Assets
How a truck transportation and logistics company leverages acquisitions and technology